Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) announced a conference call on May 10, 2022, at 8:30 a.m. ET to discuss its financial results for Q1 2022, ending March 31. The company focuses on developing therapeutics for central nervous system disorders, leveraging Nobel prize-winning research to create innovative treatments for psychiatric and neurologic diseases. Interested parties can join via phone or webcast, with dial-in details provided for participants.

NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will host a conference call and live webcast discussion at 8:30 a.m. Eastern Time on Tuesday, May 10, 2022, to provide a corporate update and discuss details of the Company's financial results for the quarter ended March 31, 2022.

To access the live conference call via phone, dial 1-(844) 835-6563. The international dial-in number is 1-(970) 315-3916. The conference ID number for the live call is 9526447.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When is Intra-Cellular Therapies' next conference call?

Intra-Cellular Therapies will host its next conference call on May 10, 2022, at 8:30 a.m. ET.

What financial results will Intra-Cellular Therapies discuss?

The company will discuss its financial results for the quarter ended March 31, 2022.

How can I access the conference call for Intra-Cellular Therapies?

The conference call can be accessed by dialing 1-(844) 835-6563 or through the live webcast available on their Investor Relations website.

What is the focus of Intra-Cellular Therapies?

Intra-Cellular Therapies focuses on developing therapeutics for central nervous system disorders, utilizing research to create innovative treatments.